OSCAR HEALTH INC

Oscar Health CFO’s modest 18,750‑share sale hints at portfolio rebalancing, not a red flag—watch insider moves for market sentiment shifts.

Oscar Health CEO sells 2.8 M shares via Rule 10b5‑1 plan; market remains bullish with a 44 % YTD rally and a low valuation—still a strong buy for long‑term investors.

Oscar Health insider buying sparks investor curiosity—insider purchases signal confidence amid negative earnings and high social‑media buzz. Explore the implications for your portfolio.

Insider buying of Oscar Health’s deferred stock units signals management confidence, hinting at future price upside amid strong recent gains and growth potential.

Mark Bertolini’s latest Oscar Health insider trades show growing confidence, aligning CEO stakes with PSUs and boosting investor optimism in a volatile healthcare‑tech market.

Oscar Health insider buying signals long‑term confidence amid a bearish market – insiders buying RSUs and selling tax‑cover shares suggest cautious optimism for future upside.

Insider buying spurs optimism for Oscar Health—Gassen William’s large deferred unit purchase hints at long‑term confidence amid enrollment headwinds.

Oscar Health CTO Mario Schlosser buys shares amid volatility: what investors should know about the signal and future outlook.